Activity-based proteome profiling of potential cellular targets of orlistat - An FDA-approved drug with anti-tumor activities

Peng Yu Yang, Kai Liu, Mun Hong Ngai, Martin J. Lear, Markus R. Wenk, Shao Q. Yao

Research output: Contribution to journalArticlepeer-review

196 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Activity-based proteome profiling of potential cellular targets of orlistat - An FDA-approved drug with anti-tumor activities'. Together they form a unique fingerprint.

Chemistry

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology